Fosun Diagnostics Obtains China Approval for SARS-CoV-2 Antigen Test

The kit detects the SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs within seven days of infection for patients with respiratory and fever symptoms.

Related Keywords

China ,Germany ,Australia ,Fosun Pharma ,China National Medical Products Administration ,European Union ,Institute For Drugs ,Shanghai Fosun Pharmaceutical ,National Medical Products Administration ,Fosun Diagnostic ,Novel Coronavirus ,Antigen Detection Kit ,Colloidal Gold ,Fosun Diagnostics ,Federal Institute ,Medical Devices ,Fosun Diagnostic Novel Coronavirus ,